Oncology 

An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition

Prof. Keiichi Fujiwara

Prof. Keiichi Fujiwara
Prof. Simon Boulton

Prof. Simon Boulton
Dr Shinji Ohno

Dr Shinji Ohno
Dr Rebecca Dent

Dr Rebecca Dent
Prof. Charlie Gourley

Prof. Charlie Gourley

Publication Date

Sep 2021

menu
temporal

DDR and PARPi Expert Forums were held with international faculty in Tokyo and Singapore during January 2020.

 

Learn about the role of PARP inhibitors in clinical practice and targeting DDR, including:

  • Mechanism of Action of PARP inhibition and targeting DDR

  • Clinical profile of PARP inhibitors and their benefit in ovarian and breast cancer

  • Appropriate patient selection for PARP inhibition

  • Future DDR and PARP inhibition

 

Prof. Keiichi Fujiwara has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Abbvie, AstraZeneca, Clovis, Eisai, MSD, Ono, Pfizer and Takeda. 

Prof. Simon Boulton has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Artios Pharma Ltd.

Dr Shinji Ohno has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Chugai, Eisai, Eli Lilly, KyowaHakko, Kirin and Taiho

Dr Rebecca Dent has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Eisai, Genentech, Lilly, Merck, Novartis, Pfizer and Roche. 

Prof. Charlie Gourley has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Apera, Clovis, MSD, Nucana, Novartis, Roche, Sierra Oncology and Tesaro. 
Programme summary
Share this programme
This educational programme is supported by an Independent Educational Grant from AstraZeneca
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

video Video
Oncology 
The emerging role of artificial intelligence in precision oncology

Expert opinion on the clinical application of artificial intelligence (AI)

Experts
Prof. Albrecht Stenzinger
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Nov 2024
PRECISION ONCOLOGY CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Bayer.
podcast Podcast
Oncology 
BRAF-mutated CRC: from testing to treatment

Medical experts share insights and review key clinical trials

Experts
Prof. Sebastian Stintzing, Dr Thomas Winder
Endorsed by
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar Nov 2024
GI CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Pierre Fabre. This content is not intended for HCPs within the UK.
other Other
Oncology 
Biomarker testing in NSCLC: patient and caregiver awareness and understanding

Findings from a global survey presented in a poster at ESMO 2024

Experts
Prof. Christian Rolfo, Prof. Fernando López-Ríos, Dr. Rodrigo Paredes, Amy Moore, Anne-Marie Baird, Shani Shilo
Endorsed by
LUNGevity
Lung Cancer Europe IASLC
The Israeli Lung Cancer Foundation ISLB
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2024
PRECISION ONCOLOGY CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Bayer.
podcast Podcast
Oncology Rare diseases 
Neuroendocrine tumours (NETs) shared decision-making: Exploring the patient journey and individualising treatments

Experts
Dr Mohid S Khan, Sally Jenkins
Endorsed by
CommNETs
NANETS
Neuroendocrine Cancer UK
The Healing NET Foundation
  • download Downloadable
    Resources
  • clock 23 MIN
  • calendar Sep 2024
NET CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Ipsen
conference-update Conference update
Oncology 
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers

Renowned medical experts share their insights into new data presented at ESMO 2024

  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2024
COR2ED Non-accredited Independent Medical Education
animated-video Animated Video

Episode

1

of 1

episode
Oncology 
Precision oncology in prostate cancer: tips for optimal genomic testing

From sample collection through to diagnostic modalities 

Experts
Dr Alexander Wyatt
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2024
PRECISION ONCOLOGY CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.
Explore all programmes